Clinical Trials

21 enrolled 32 charts

Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00244933 2023-06-22

Gemcitabine Hydrochloride and Genistein in Treating Women With Stage IV Breast Cancer

19 enrolled 5 charts

Breast

Breast Neoplasms

NCT02766478 2022-09-27

GeniPro

Phase 2 Terminated

10 enrolled 10 charts

Prostatic Neoplasms

NCT00118040 2021-06-10

Phase II Study of Isoflavone G-2535 (Genistein) in Patients With Bladder Cancer

60 enrolled 24 charts

Urinary Bladder Neoplasms

NCT00376948 2021-03-01

Genistein, Gemcitabine, and Erlotinib in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer

20 enrolled 11 charts

Pancreatic Neoplasms

NCT00882765 2020-07-31

Genistein in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery

Phase 2 Withdrawn

Pancreatic Neoplasms

NCT02075112 2019-12-06

Soy Isoflavone in Combination With Radiation Therapy and Cisplatin in SCC of the Head and Neck

Phase 1 Completed

24 enrolled

Head & Neck

Head and Neck Neoplasms

NCT01126879 2019-09-10

Genistein in Treating Patients With Prostate Cancer

Phase 2 Terminated

12 enrolled 8 charts

Prostatic Neoplasms

NCT01985763 2019-05-10

Genistein in Treatment of Metastatic Colorectal Cancer

13 enrolled 17 charts

BreastDermatologicGenitourinaryThoracic

Colonic Neoplasms, Neoplasm Metastasis, Rectal Neoplasms, Colorectal Neoplasms

NCT00769990 2017-12-13

Genistein in Treating Patients Undergoing External-Beam Radiation Therapy for Bone Metastases

Phase 1/2 Withdrawn

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Kidney Neoplasms, Lung Neoplasms, Melanoma, Neoplasm Metastasis, Pain, Prostatic Neoplasms, Small Cell Lung Carcinoma

NCT02499861 2017-11-17

Phase I/II a Study of Decitabine in Combination With Genistein in Pediatric Relapsed or Refractory Malignancies

6 enrolled

Tumor-Agnostic

Neoplasms

NCT00290758 2017-02-08

Genistein in Preventing Breast Cancer in Women at High Risk for Breast Cancer

126 enrolled 16 charts

Breast

Breast Neoplasms

NCT01325311 2016-08-03

Cholecalciferol and Genistein Before Surgery in Treating Patients With Early Stage Prostate Cancer

15 enrolled 21 charts

Prostatic Neoplasms

NCT01628471 2015-09-23

MTD Determination, Safety and Efficacy of the Decitabine-Genistein Drug Combination in Advanced Solid Tumors and Non-Small Cell Lung Cancer

Phase EARLY_PHASE1 Completed

20 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT00276835 2015-04-10

Genistein and Interleukin-2 in Treating Patients With Metastatic Melanoma or Kidney Cancer

15 enrolled

DermatologicGenitourinary

Carcinoma, Renal Cell, Kidney Neoplasms, Melanoma

NCT01182246 2014-04-23

AXP107-11 in Combination With Standard Gemcitabine (Gemzar® ) Therapy for Treatment in Patients With Pancreatic Cancer

Phase 1/2 Unknown

44 enrolled

Adenocarcinoma, Pancreatic Neoplasms

NCT00099008 2013-05-21

Genistein in Preventing Breast or Endometrial Cancer in Healthy Postmenopausal Women

Phase 1 Completed

30 enrolled

BreastGynecologic

Breast Neoplasms, Endometrial Neoplasms

NCT00058266 2012-07-19

Genistein in Treating Patients With Localized Prostate Cancer Who Are Planning to Undergo Radical Prostatectomy

Phase 2 Terminated

36 enrolled

Prostatic Neoplasms

NCT00005827 2012-04-24

Genistein in Treating Patients With Stage II, Stage III, or Stage IV Prostate Cancer

Phase 1 Withdrawn

Prostatic Neoplasms

NCT00546039 2008-09-30

Synthetic Genistein (BONISTEIN™) in Patients Who Are Undergoing Surgery for Prostate Cancer

Phase 2 Unknown

47 enrolled

Prostatic Neoplasms

NCT00001696 2008-03-04

A Pharmacokinetic Study of Genistein, a Tyrosine Kinase Inhibitor

Phase 1 Completed

15 enrolled